EFH
MIST icon

Eaton Financial Holdings’s Milestone Pharmaceuticals MIST Stock Holding History

Eaton Financial Holdings’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Sell
10,250
-2,500
-20% -$4.38K ﹤0.01% 125
2025
Q4 		$25.8K Buy
+12,750
New +$27.5K 0.01% 133

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Eaton Financial Holdings's MIST Position: Q1 2026 in Review

Eaton Financial Holdings reduced its Milestone Pharmaceuticals (MIST) stake by 20% in Q1 2026, selling an estimated $4.38K and leaving 10,250 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #125.

Eaton Financial Holdings first reported a position in MIST in Q4 2025 and has held it in 2 quarters since. The position peaked at $25.8K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Eaton Financial Holdings held 10,250 shares of Milestone Pharmaceuticals worth $12.2K as of Q1 2026.
  • Eaton Financial Holdings sold 2,500 Milestone Pharmaceuticals shares in Q1 2026, an estimated $4.38K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Eaton Financial Holdings's portfolio in Q1 2026, its #125 holding.
  • Eaton Financial Holdings first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Eaton Financial Holdings's Milestone Pharmaceuticals position peaked at $25.8K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Eaton Financial Holdings's 13F filing for Q1 2026, filed 15 Apr 2026.